Literature DB >> 24037119

A case of 5-FU-related severe toxicity associated with the p.Y186C DPYD variant.

A Zaanan1, L-M Dumont2, M-A Loriot3, J Taieb4, C Narjoz3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24037119     DOI: 10.1038/clpt.2013.183

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  6 in total

1.  Novel Deleterious Dihydropyrimidine Dehydrogenase Variants May Contribute to 5-Fluorouracil Sensitivity in an East African Population.

Authors:  T Elraiyah; C R Jerde; S Shrestha; R Wu; Q Nie; N H Giama; V Sarangi; L R Roberts; S M Offer; R B Diasio
Journal:  Clin Pharmacol Ther       Date:  2016-11-26       Impact factor: 6.875

Review 2.  Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective.

Authors:  Keneuoe Cecilia Nthontho; Andrew Khulekani Ndlovu; Kirthana Sharma; Ishmael Kasvosve; Daniel Louis Hertz; Giacomo Maria Paganotti
Journal:  Pharmgenomics Pers Med       Date:  2022-06-21

3.  Response to "A case of 5-FU-related severe toxicity associated with the P.Y186C DPYD variant".

Authors:  S M Offer; R B Diasio
Journal:  Clin Pharmacol Ther       Date:  2013-10-09       Impact factor: 6.875

Review 4.  Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature.

Authors:  Cassandra White; Rodney J Scott; Christine Paul; Andrew Ziolkowski; David Mossman; Stephen Ackland
Journal:  Pharmgenomics Pers Med       Date:  2021-12-09

Review 5.  Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil Therapy.

Authors:  Robert B Diasio; Steven M Offer
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

6.  Population-scale predictions of DPD and TPMT phenotypes using a quantitative pharmacogene-specific ensemble classifier.

Authors:  Yitian Zhou; Carolina Dagli Hernandez; Volker M Lauschke
Journal:  Br J Cancer       Date:  2020-09-25       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.